CMO 11 Protective Order : Judge Marston approved a joint motion from the parties to safeguard certain discovery materials from public access, including personal health information and confidential commercial data
In this post, I take a deep dive into EVOKE and EVOKE+, examining trial design, endpoints, effect sizes, and interpretability
Routine testosterone monitoring is not recommended for all patients taking semaglutide, as there is no evidence that the medication causes clinically significant testosterone suppression requiring systematic surveillance
Some patients notice loose skin after significant weight loss, while others see facial volume changes, skin laxity, or changes in their buttocks, abdomen, thighs, arms, or breasts
The overlap problem Nausea and abdominal discomfort are common semaglutide side effects
Before You Enroll: 9 Things to Verify Before signing up for any telehealth GLP-1 program, consider verifying these details directly with the platform: 1